Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

ZENTALIS PHARMACEUTICALS INC COM (ZNTL)

81 + Investors. Track Smart Money conviction in ZNTL. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -15
Streak
4Q ▼
Buyers last Q
43%

Smart Money Signals — ZNTL

Based on 81 hedge funds · latest filing: 2025 Q4 · updated quarterly

📉

Selling streak — 4 quarters in a row

last 6Q
For 4 consecutive quarters, more hedge funds reduced or closed their ZNTL positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🔻

Below peak — only 57% of 3.0Y high

57% of all-time peak
Only 81 funds hold ZNTL today versus a peak of 141 funds at 2024 Q4 — just 57% of the maximum. Low institutional ownership can mean the stock is out of favor, but it also means there's a large pool of potential buyers if sentiment turns.
📉

Outflows — 43% fewer funds vs a year ago

fund count last 6Q
60 fewer hedge funds hold ZNTL compared to a year ago (-43% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟠

More sellers than buyers — 43% buying

37 buying50 selling
Last quarter: 50 funds reduced or exited vs 37 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
➡️

Steady new buyers — ~8 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 16 → 21 → 5 → 8. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

52% of holders stayed for 2+ years

■ 52% conviction (2yr+) ■ 32% medium ■ 16% new
42 out of 81 hedge funds have held ZNTL for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares -23%, value -98%

Value
-97%
Shares
-23%
Last quarter: funds added -23% more shares while total portfolio value only changed -98%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
⚠️

Saturation — most institutions already know this story

31 → 16 → 21 → 5 → 8 new funds/Q
New funds entering each quarter: 16 → 21 → 5 → 8. Far fewer institutions are entering now vs. a year ago. When the pool of potential new buyers shrinks this fast, future price support from institutional inflows weakens significantly.
🏛️

Deep conviction — 58% of holders stayed 2+ years

■ 58% veterans ■ 17% 1-2yr ■ 25% new
Of 81 current holders: 47 (58%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
✅

Strong quality — 20% AUM from major funds

20% from top-100 AUM funds
16 of 81 holders rank in the top 100 by AUM, accounting for 20% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
1.6
out of 10
Low Exit Risk
Exit risk score 1.6/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ZNTL

In 2025 Q4, 37 hedge funds were net buyers of ZNTL (8 opened a new position, 29 added to an existing one), while 50 reduced or exited (27 trimmed, 23 sold completely) — a 43% buyer ratio, indicating roughly balanced activity. This extends a 4-quarter selling streak, suggesting sustained institutional caution. 20% of total institutional value in ZNTL is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: -15 funds (more exits than new entries). Total institutional holders: 81.

Hedge Fund Ownership: ZNTL

How many hedge funds hold ZNTL — quarterly history vs. share price
Quarterly hedge fund ownership of ZNTL vs. share price

Market Analysis: ZNTL

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ZNTL

Healthcare Biotechnology

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

17 top-rated funds 0 high-conviction
Consensus
5.5
/ 10
breadth
×
Elite
0.7
/ 10
conviction
Hedge Fund Positioning: ZNTL
2026 Q1 Stats Unlock in 7 days 81 + Investors

Track Smart Money conviction in ZNTL. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 81 98 -17.35%
13F Shares 40M 52M -23.2%
Total Value $54M $2.21B -97.55%
New Positions 8 5 +3
Increased Positions 29 35 -6
Closed Positions 23 21 +2
Reduced Positions 28 36 -8
Total Calls 0 0 -
Total Puts 0 2 -100.0%
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: ZNTL

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

81 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ZNTL. Verified SEC 13F-HR filings.

Top 25 institutional holders of ZNTL — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 PFIZER INC 0.84% 953,834 $2.0M
2 Peapod Lane Capital LLC 0.68% 366,868 $835K
3 Decheng Capital LLC 0.47% 1,323,327 $3.1M
4 Anfield Capital Management, LLC 0.18% 274,516 $642K
5 GSA CAPITAL PARTNERS LLP 0.09% 620,407 $1K
6 Regency Capital Management Inc.\DE 0.03% 29,500 $69K
7 Carson Advisory Inc. 0.03% 23,270 $54K
8 BARR E S & CO 0.01% 110,000 $257K
9 49 WEALTH MANAGEMENT, LLC 0.01% 66,401 $155K
10 ACADIAN ASSET MANAGEMENT LLC 0.01% 2,848,252 $7K
11 Sivia Capital Partners, LLC 0.01% 20,000 $47K
12 Catalyst Funds Management Pty Ltd 0.01% 16,700 $39K
13 Connor, Clark & Lunn Investment Management Ltd. 0.00% 792,001 $1.9M
14 PRIMECAP MANAGEMENT CO/CA/ 0.00% 957,420 $2.2M
15 Cornerstone Wealth Management, LLC 0.00% 10,186 $24K
16 Hudson Bay Capital Management LP 0.00% 117,127 $274K
17 BNP PARIBAS FINANCIAL MARKETS 0.00% 471,438 $1.1M
18 Creative Planning 0.00% 285,000 $667K
19 WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 0.00% 78,740 $207K
20 Private Advisor Group, LLC 0.00% 31,472 $74K
21 FEDERATED HERMES, INC. 0.00% 65,520 $153K
22 COMMONWEALTH EQUITY SERVICES, LLC 0.00% 61,412 $144K
23 VANGUARD FIDUCIARY TRUST CO 0.00% 304,471 $712K
24 JANE STREET GROUP, LLC 0.00% 490,339 $1.1M
25 VANGUARD CAPITAL MANAGEMENT LLC 0.00% 2,310,707 $5.4M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — ZENTALIS PHARMACEUTICALS INC COM (ZNTL)

What does the Smart Money Trend signal show for ZNTL?

Selling streak — 4 quarters in a row: For 4 consecutive quarters, more hedge funds reduced or closed their ZNTL positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for ZNTL?

More sellers than buyers — 43% buying: Last quarter: 50 funds reduced or exited vs 37 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for ZNTL holders?

Strong quality — 20% AUM from major funds: 16 of 81 holders rank in the top 100 by AUM, accounting for 20% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held ZNTL?

52% of holders stayed for 2+ years: 42 out of 81 hedge funds have held ZNTL for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.